Search details
1.
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
Nat Immunol
; 22(1): 74-85, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32999467
2.
Development and validation of a respiratory syncytial virus multiplex immunoassay.
Infection
; 52(2): 597-609, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38332255
3.
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants.
Clin Infect Dis
; 76(3): e240-e249, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-35717657
4.
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies.
EMBO Rep
; 22(5): e52325, 2021 05 05.
Article
in English
| MEDLINE | ID: mdl-33904225
5.
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination.
Emerg Infect Dis
; 28(4): 743-750, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35203113
6.
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
BMC Med
; 20(1): 102, 2022 03 03.
Article
in English
| MEDLINE | ID: mdl-35236358
7.
Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies.
BMC Infect Dis
; 22(1): 859, 2022 Nov 17.
Article
in English
| MEDLINE | ID: mdl-36396985
8.
RhoA determines disease progression by controlling neutrophil motility and restricting hyperresponsiveness.
Blood
; 123(23): 3635-45, 2014 Jun 05.
Article
in English
| MEDLINE | ID: mdl-24782506
9.
Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel.
Int J Infect Dis
; 139: 50-58, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38008353
10.
Seroprevalence of Hepatitis E virus in children and adolescents living in urban Bogotá: An explorative cross-sectional study.
Front Public Health
; 11: 981172, 2023.
Article
in English
| MEDLINE | ID: mdl-36844812
11.
Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test.
J Vis Exp
; (197)2023 Jul 14.
Article
in English
| MEDLINE | ID: mdl-37522730
12.
Humoral immune response to SARS-CoV-2 and endemic coronaviruses in urban and indigenous children in Colombia.
Commun Med (Lond)
; 3(1): 151, 2023 Oct 20.
Article
in English
| MEDLINE | ID: mdl-37864073
13.
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients.
Front Immunol
; 13: 1004045, 2022.
Article
in English
| MEDLINE | ID: mdl-36275672
14.
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations.
Sci Rep
; 12(1): 19858, 2022 11 18.
Article
in English
| MEDLINE | ID: mdl-36400804
15.
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany.
Front Immunol
; 13: 828053, 2022.
Article
in English
| MEDLINE | ID: mdl-35251012
16.
Direct and Indirect Proof of SARS-CoV-2 Infections in Indigenous Wiwa Communities in North-Eastern Colombia-A Cross-Sectional Assessment Providing Preliminary Surveillance Data.
Vaccines (Basel)
; 9(10)2021 Oct 01.
Article
in English
| MEDLINE | ID: mdl-34696227
17.
SARS-CoV-2 Seroprevalence in Germany.
Dtsch Arztebl Int
; 118(48): 824-831, 2021 12 03.
Article
in English
| MEDLINE | ID: mdl-35191825
18.
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis.
EBioMedicine
; 70: 103524, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34391096
19.
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.
Nat Commun
; 12(1): 3109, 2021 05 25.
Article
in English
| MEDLINE | ID: mdl-34035301
20.
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity.
Nat Commun
; 12(1): 1152, 2021 02 19.
Article
in English
| MEDLINE | ID: mdl-33608538